Gateway Foundation Chicago West

Gateway Foundation Chicago West

Services:
External Opioid Medications Source
• No formal relationship with prescribing entity
• Other contracted prescribing entity

Age Groups Accepted

• Adults
• Young Adults

External Source of Medications Used for Alcohol Use Disorder Treatment

• No formal relationship with prescribing entity

Gender Accepted

• Male
• Female

Ancillary Services

• Early intervention for HIV
• Case management service
• Mental health services
• Transportation assistance
• Suicide prevention services
• Domestic violence services, including family or partner
• Social skills development

Opioid Medications used in Treatment

• Naltrexone used in Treatment
• Buprenorphine used in Treatment

Education and Counseling Services

• Family counseling
• Hepatitis education, counseling, or support
• Substance use disorder education
• Individual counseling
• HIV or AIDS education, counseling, or support
• Marital/couples counseling
• Group counseling
• Health education services other than HIV/AIDS or hepatitis
• Smoking/vaping/tobacco cessation counseling

Transitional Services

• Aftercare/continuing care
• Naloxone and overdose education
• Outcome follow-up after discharge
• Discharge Planning

Testing

• TB screening
• HIV testing
• Drug or alcohol urine screening
• STD testing
• Testing for Hepatitis B (HBV)
• Testing for Hepatitis C (HCV)
• Breathalyzer or blood alcohol testing

Facility Vaping Policy

• Vaping not permitted

Treatment Approaches

• Telemedicine/telehealth therapy
• Substance use disorder counseling
• Brief intervention
• 12-step facilitation
• Community reinforcement plus vouchers
• Relapse prevention
• Contingency management/motivational incentives
• Anger management
• Cognitive behavioral therapy
• Trauma-related counseling
• Motivational interviewing

Pharmacotherapies

• Clonidine
• Medication for mental disorders
• Naltrexone (oral)
• Nicotine replacement
• Buprenorphine with naloxone
• Naltrexone (extended-release, injectable)
• Disulfiram
• Non-nicotine smoking/tobacco cessation
• Buprenorphine without naloxone
• Acamprosate (Campral®)
• Buprenorphine (extended-release, injectable)
• Medications for HIV treatment
• Medications for pre-exposure to prophylaxis

Facility Operation (e.g., Private, Public)

• Private non-profit organization

Other Services

• Treatment for gambling disorder

License/Certification/Accreditation

• State Substance use treatment agency
• State department of health
• Drug Enforcement Agency (DEA)
• The Joint Commission

Payment Assistance Available

• Sliding fee scale (fee is based on income and other factors)

Facility Smoking Policy

• Smoking permitted in designated area

Language Services

• Other languages (excluding Spanish)
• Spanish

Assessment/Pre-treatment

• Comprehensive substance use assessment
• Complete medical history/physical exam
• Screening for tobacco use
• Interim services for clients
• Comprehensive mental health assessment
• Screening for mental disorders
• Outreach to persons in the community
• Screening for substance use

Payment/Insurance/Funding Accepted

• Private health insurance
• Cash or self-payment
• Medicaid
• Federal, or any government funding for substance use treatment programs

Special Programs/Groups Offered

• Clients who have experienced trauma
• Veterans
• Clients who have experienced sexual abuse
• Clients who have experienced intimate partner violence, domestic violence
• Lesbian, gay, bisexual, transgender, or queer/questioning (LGBTQ)
• Clients with co-occurring mental and substance use disorders
• Adult men
• Seniors or older adults
• Adult women

Type of Alcohol Use Disorder Treatment

• This facility administers/prescribes medication for alcohol use disorder
• Accepts clients using medication assisted treatment for alcohol use disorder but prescribed elsewhere

Other Languages

• Polish

Type of Opioid Treatment

• Prescribes naltrexone
• Maintenance service with medically supervised withdrawal after stabilization
• Accepts clients using MAT but prescribed elsewhere
• Prescribes buprenorphine

Recovery Support Services

• Mentoring/peer support
• Assistance with obtaining social services
• Self-help groups

Type of Care

• Substance use treatment
• Transitional housing, halfway house, or sober home
• Treatment for co-occurring substance use plus either serious mental health illness in adults/serious emotional disturbance in children

Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)

• Short-term residential
• Residential/24-hour residential
• Hospital inpatient treatment
• Regular outpatient treatment
• Outpatient
• Outpatient day treatment or partial hospitalization
• Intensive outpatient treatment
• Outpatient methadone/buprenorphine or naltrexone treatment
• Hospital inpatient/24-hour hospital inpatient